NTLA 250117 15.00P (NTLA250117P15000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

NTLA250117P15000

Watchlist

3.41
+1.35+65.53%

15min DelayClose Jan 8 16:00 ET

3.41High3.40Low

Intraday

5D
Daily

News

Evercore Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Cuts Target Price to $48
Moomoo News26minutes ago · Ratings
Intellia Therapeutics (NTLA) Receives a Buy From Evercore ISI
TipRanks32minutes ago · Ratings
Intellia Therapeutics Restructures to Focus on Late-Stage Programs
TipRanks57minutes ago
Wells Fargo Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $60
Moomoo News07:34 ET · Ratings
Wells Fargo Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Cuts Target Price to $60
Moomoo News06:31 ET · Ratings
Express News | Intellia Therapeutics Inc : Wells Fargo Cuts Target Price to $60 From $70
Reuters05:39 ET

Comments

70107480

Jan 6 04:45

$Intellia Therapeutics (NTLA.US)$ The future is brighter than we realize.

Big Wealthy Rat

Dec 13, 2024 09:13

$Intellia Therapeutics (NTLA.US)$ Such a discounted price!

Big Wealthy Rat

Dec 10, 2024 12:21

$Intellia Therapeutics (NTLA.US)$ Yep, it's fly time!

Big Wealthy Rat

Dec 6, 2024 14:08

$Intellia Therapeutics (NTLA.US)$ This is such a buy right now. Cup and handle almost complete, downtrend reversing, the boomers who hold most of the wealth want to live as long as possible, and NTLA seems to have found a way to stop one age-related disorder (ATTR-amyloidosis). This is so going to the moon next year!

YWCYAPWEICHOY 叶伟财

Oct 21, 2024 03:06

Cathie Wood's ARK buys CRISPR, Intellia stock, sells Moderna

time to buy the stock?